Extensive vitiligo after ganciclovir treatment of GVHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase

Lancet

Volumn 355, Issue 9204, 2000, Pages 626-627

  Aubin, F ^a   Cahn, J Y ^a   Ferrand, C ^a   Angonin, R ^a   Humbert, P ^a   Tiberghien, P ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; GANCICLOVIR; IMMUNOGLOBULIN; THIOTEPA; THYMIDINE KINASE; VIRUS ENZYME;

ADOPTIVE IMMUNOTHERAPY; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; GRAFT REJECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SUICIDE GENE; T LYMPHOCYTE; VITILIGO;

EID: 0034685197     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)04215-4     Document Type: Article

References (5)

1. Tiberghien P., Cahn J.Y., Brion A.et al. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II study. Hum Gene Ther. 8:1997;615-624.
2. Tiberghien P. Suicide gene for the control of graft-versus-host disease. Curr Opin Hematol. 5:1998;478-482.
3. Johnson M.L., Farmer F.R. Graft-versus-host reactions in dermatology. J Am Acad Dermatol. 38:1998;369-392.
4. Kawakami Y., Robbins P.F., Wang R.F., Parkhurst M., Kang X., Rosenberg S.A. The use of melanosomal proteins in the immunotherapy of melanoma. J Immunother Emphasis Tumour Immunol. 21:1998;237-246.
5. Culver K.W., Ram Z., Wallbridge S., Ishii H., Oldfield E.H., Blaese R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumours. Science. 256:1992;1550-1552.